Keyphrases
Chemotherapy
100%
Meta-analysis
100%
Randomized Trial
100%
Metastatic Colorectal Cancer (mCRC)
100%
Molecular Targeted Agents
100%
Second-line Therapy
100%
Chemotherapy Alone
71%
Confidence Interval
57%
Adverse Events
57%
Overall Survival
42%
Progression-free Survival
42%
Risk Ratio
42%
Objective Response Rate
42%
VEGF Inhibitors
42%
Hazard Ratio
28%
Combination Therapy
28%
Randomized Controlled Trial
28%
Pathway Inhibitors
28%
Survival Response
28%
Targeted Agents
14%
High Risk
14%
Statistical Analysis
14%
Data Extraction
14%
Epidermal Growth Factor Receptor
14%
Information Retrieval
14%
Biological Agents
14%
Inclusion Criteria
14%
Subgroup Analysis
14%
Embase
14%
PubMed
14%
Information Data
14%
Vascular Endothelial Growth Factor Inhibitors
14%
Stata
14%
Epidermal Growth Factor Receptor Inhibitors
14%
Information Screening
14%
Extracted Data
14%
Endothelial Growth Factor
14%
Medicine and Dentistry
Adverse Event
100%
Meta-Analysis
100%
Metastatic Colorectal Cancer
100%
Vasculotropin Inhibitor
100%
Overall Survival
75%
Progression Free Survival
75%
Combination Therapy
50%
Hazard Ratio
50%
Randomized Controlled Trial
50%
Arm
50%
Biological Product
25%
Epidermal Growth Factor Receptor
25%
Subgroup Analysis
25%
Epidermal Growth Factor Receptor Kinase Inhibitor
25%
Endothelial Cell Growth Factor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Metastatic Colorectal Cancer
100%
Adverse Event
33%
Vasculotropin Inhibitor
33%
Overall Survival
25%
Progression Free Survival
25%
Randomized Controlled Trial
16%
Combination Therapy
16%
Biological Product
8%
Epidermal Growth Factor Receptor Kinase Inhibitor
8%
Endothelial Cell Growth Factor
8%
Epidermal Growth Factor Receptor
8%